TIANFU CHEM Ruxolitinib phosphate

Min.Order / FOB Price:Get Latest Price

1 Kilogram	Negotiable

1 Kilogram

Negotiable

Min.Order :1 Kilogram
Purity: 98%
Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram

Keywords

Ruxolitinib phosphate 1092939-17-7 TIANFU CHEM Ruxolitinib phosphate

Quick Details

Appearance:White powder
Application:Intermediates
PackAge:as requested
ProductionCapacity:100|Kilogram|Month
Storage:room temperature
Transportation:by sea, by air or by courier

Superiority:

Our company was built in 2009 with an ISO certificate.

In the past 5 years, we have grown up as a famous fine chemicals supplier in China and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.

Our main business covers the fields below:

1.Noble Metal Catalysts (Pt.Pd...)

2.Organic Phosphine Ligands (Tert-butyl-phosphine.Cyclohexyl-phosphine...)

3.OLED intermediates (Fluorene,Carbazole,Boric acid...)

4.Customs Synthesis

Our advantage:

1.Higest quality and good package

2.Fast delivery

3.Better payment term

4.Fast response to customer within 6 hours

5.Good business credit in Europe ,US ,Japan ,Korea

Details:

Ruxolitinib phosphate Basic information
Product Name: Ruxolitinib phosphate
Synonyms: (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile phosphate;INCB 018424;Ruxolitinib, Phosphate Salt;Ruxolitinib, Phosphate;(βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile Phosphate;INCB 018424(Ruxolitinib Phosphate);INCB 018424 (phosphate);INCB018424 (phosphate)
CAS: 1092939-17-7
MF: C17H18N6.H3PO4
MW: 404.360201
EINECS:
Product Categories: Intracellular signaling.;Antineoplastic;Inhibitors
Mol File: 1092939-17-7.mol

Ruxolitinib phosphate Usage And Synthesis

Uses The phosphate salt of Ruxolitinib (R702000). Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.

Definition ChEBI: A phosphate salt obtained by reaction ruxolitinib with one equivalent of phosphoric acid. Used for the treatment of patients with intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post-essent al thrombocythemia myelofibrosis.

View All

Visit Store